About this trial
The investigators will conduct a trial to evaluate if an online training and support platform can help adults living with type 1 diabetes (T1D) in their diabetes self-management. Investigators will compare a group that has access to the "Support" platform through their usual medical care to a group that accesses the platform independently. The first group will be recruited through four participating clinics in the province of Quebec (Canada). The second group will be composed of adults living with T1D across Canada. Participants will have access to the platform for 12 months and will be asked to complete online questionnaires at the beginning and after 6 and 12 months, and share their glucose reader data with the research team. A subgroup of participants as well as healthcare professionals from the four clinics will be invited to participate in an individual interview aiming to understand the barriers and facilitators of integration "Support" in clinical care.
Eligibility criteria
Qualifiers
Diagnosis of T1D (including LADA - latent autoimmune diabetes in adults)
Have access to Internet
Use of an active email address
Comprehension of English or French
Disqualifiers
None
Trial design
Treatments tested in this trial
- Support platform
Treatment groups
Sponsors and collaborators
McGill University
Lead sponsor
Institut de Recherches Cliniques de Montreal
Collaborator
Centre de Recheche du Centre Hospitalier Université Laval
Collaborator
Centre hospitalier de l'Université de Montréal (CHUM)
Collaborator
Centre de médecine métabolique de Lanaudière
Collaborator